Structural Biology in Drug Discovery 2020
DOI: 10.1002/9781118681121.ch20
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Protein–Protein Interactions Perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 160 publications
0
2
0
Order By: Relevance
“…Nowadays, exploring the druggability of certain PPIs remains a very challenging topic in drug discovery . In most cases, this is due to the limitations of biophysical assays, which are not always able to overcome obstacles from a structural biology perspective.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nowadays, exploring the druggability of certain PPIs remains a very challenging topic in drug discovery . In most cases, this is due to the limitations of biophysical assays, which are not always able to overcome obstacles from a structural biology perspective.…”
Section: Discussionmentioning
confidence: 99%
“…Nowadays, exploring the druggability of certain PPIs remains a very challenging topic in drug discovery. 31 In most cases, this is due to the limitations of biophysical assays, which are not always able to overcome obstacles from a structural biology perspective. For this reason, it is necessary to use a wide range of techniques in combination with computational approaches in order to investigate potential hot spots of a PPI complex as well as to monitor the conformational changes of such system in terms of space and time.…”
Section: ■ Conclusionmentioning
confidence: 99%